- 全部删除
 
您的购物车当前为空
Icosabutate (NST-4016) 是一种具有口服活性的二十碳五烯酸的衍生物,可抑制 NASH 的肝脏炎症和纤维化,可改善他汀类药物治疗的残留高甘油三酯血症患者的心血管风险状况,降低甘油三脂,可用于研究肝纤维化和动脉粥样硬化。


为众多的药物研发团队赋能,
让新药发现更简单!
Icosabutate (NST-4016) 是一种具有口服活性的二十碳五烯酸的衍生物,可抑制 NASH 的肝脏炎症和纤维化,可改善他汀类药物治疗的残留高甘油三酯血症患者的心血管风险状况,降低甘油三脂,可用于研究肝纤维化和动脉粥样硬化。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 892  | In stock | |
| 5 mg | ¥ 1,990  | In stock | |
| 10 mg | ¥ 2,970  | In stock | |
| 25 mg | ¥ 4,910  | In stock | |
| 50 mg | ¥ 6,870  | In stock | |
| 100 mg | ¥ 9,260  | In stock | |
| 200 mg | ¥ 12,300  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,630  | In stock | 
| 产品描述 | Icosabutate (NST-4016) is an orally active derivative of eicosapentaenoic acid that inhibits hepatic inflammation and fibrosis in NASH, improves cardiovascular risk profiles in statin-treated patients with residual hypertriglyceridemia, lowers triglycerides, and may be useful in studies of liver fibrosis and atherosclerosis.  | 
| 体内活性 | 在 6-8 周龄的 ob/ob 雄性小鼠中,Icosabutate(每日通过饮食给予 135 mg/kg;连续给药 5 周)能够改善葡萄糖代谢和胰岛素抵抗[1]。  | 
| 别名 | 艾考布特, PRC-4016, NST-4016 | 
| 分子量 | 374.56 | 
| 分子式 | C24H38O3 | 
| CAS No. | 1253909-57-7 | 
| Smiles | CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCOC(CC)C(O)=O | 
| 密度 | 1.31g/cm3 | 
| 存储 | Pure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (213.58 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容